A citation-based method for searching scientific literature

Céline Mazzotti, Laure Buisson, Sabrina Maheo, Aurore Perrot, Marie-Lorraine Chretien, Xavier Leleu, Cyrille Hulin, Salomon Manier, Benjamin Hébraud, Murielle Roussel, Laura Do Souto, Michel Attal, Hervé Avet-Loiseau, Jill Corre. Blood Adv 2018
Times Cited: 47







List of co-cited articles
535 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, Brian Durie, Ola Landgren, Philippe Moreau, Nikhil Munshi, Sagar Lonial, Joan Bladé, Maria-Victoria Mateos,[...]. Lancet Oncol 2016
68

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
Aurore Perrot, Valerie Lauwers-Cances, Jill Corre, Nelly Robillard, Cyrille Hulin, Marie-Lorraine Chretien, Thomas Dejoie, Sabrina Maheo, Anne-Marie Stoppa, Brigitte Pegourie,[...]. Blood 2018
214
65

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.
J Flores-Montero, L Sanoja-Flores, B Paiva, N Puig, O García-Sánchez, S Böttcher, V H J van der Velden, J-J Pérez-Morán, M-B Vidriales, R García-Sanz,[...]. Leukemia 2017
323
65

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA.
Anna Oberle, Anna Brandt, Minna Voigtlaender, Benjamin Thiele, Janina Radloff, Anita Schulenkorf, Malik Alawi, Nuray Akyüz, Manuela März, Christopher T Ford,[...]. Haematologica 2017
72
59

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.
Nikhil C Munshi, Herve Avet-Loiseau, Andy C Rawstron, Roger G Owen, J Anthony Child, Anjan Thakurta, Paul Sherrington, Mehmet Kemal Samur, Anna Georgieva, Kenneth C Anderson,[...]. JAMA Oncol 2017
298
51

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Olena Kis, Rayan Kaedbey, Signy Chow, Arnavaz Danesh, Mark Dowar, Tiantian Li, Zhihua Li, Jessica Liu, Mark Mansour, Esther Masih-Khan,[...]. Nat Commun 2017
77
46

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma.
Joaquin Martinez-Lopez, Juan J Lahuerta, François Pepin, Marcos González, Santiago Barrio, Rosa Ayala, Noemí Puig, María A Montalban, Bruno Paiva, Li Weng,[...]. Blood 2014
300
42

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA: A Pilot Study.
Giulia Biancon, Silvia Gimondi, Antonio Vendramin, Cristiana Carniti, Paolo Corradini. J Mol Diagn 2018
28
71

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
S Manier, J Park, M Capelletti, M Bustoros, S S Freeman, G Ha, J Rhoades, C J Liu, D Huynh, S C Reed,[...]. Nat Commun 2018
104
40

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials.
Juan-Jose Lahuerta, Bruno Paiva, Maria-Belen Vidriales, Lourdes Cordón, Maria-Teresa Cedena, Noemi Puig, Joaquin Martinez-Lopez, Laura Rosiñol, Norma C Gutierrez, María-Luisa Martín-Ramos,[...]. J Clin Oncol 2017
177
38

Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.
Philippe Moreau, Michel Attal, Denis Caillot, Margaret Macro, Lionel Karlin, Laurent Garderet, Thierry Facon, Lotfi Benboubker, Martine Escoffre-Barbe, Anne-Marie Stoppa,[...]. J Clin Oncol 2017
170
36

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
María-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Polina Kaplan,[...]. N Engl J Med 2018
579
36

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
Guangwu Guo, Noopur S Raje, Charles Seifer, Jake Kloeber, Randi Isenhart, Gavin Ha, Andrew J Yee, Elizabeth K O'Donnell, Yu-Tzu Tai, Paul G Richardson,[...]. Leukemia 2018
33
51

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.
L Rasche, S S Chavan, O W Stephens, P H Patel, R Tytarenko, C Ashby, M Bauer, C Stein, S Deshpande, C Wardell,[...]. Nat Commun 2017
190
36

Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy.
Luzalba Sanoja-Flores, Juan Flores-Montero, Noemi Puig, Teresa Contreras-Sanfeliciano, Roberia Pontes, Alba Corral-Mateos, Omar García-Sánchez, María Díez-Campelo, Roberto José Pessoa de Magalhães, Luis García-Martín,[...]. Blood 2019
39
43

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.
Michel Attal, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Denis Caillot, Martine Escoffre, Bertrand Arnulf, Margaret Macro, Karim Belhadj, Laurent Garderet,[...]. N Engl J Med 2017
640
34

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
589
34

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
Neha Korde, Mark Roschewski, Adriana Zingone, Mary Kwok, Elisabet E Manasanch, Manisha Bhutani, Nishant Tageja, Dickran Kazandjian, Sham Mailankody, Peter Wu,[...]. JAMA Oncol 2015
226
34

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
Bruno Paiva, Noemi Puig, Maria-Teresa Cedena, Laura Rosiñol, Lourdes Cordón, María-Belén Vidriales, Leire Burgos, Juan Flores-Montero, Luzalba Sanoja-Flores, Lucia Lopez-Anglada,[...]. J Clin Oncol 2020
112
34

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study.
Andy C Rawstron, J Anthony Child, Ruth M de Tute, Faith E Davies, Walter M Gregory, Sue E Bell, Alexander J Szubert, Nuria Navarro-Coy, Mark T Drayson, Sylvia Feyler,[...]. J Clin Oncol 2013
305
31


Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Jens G Lohr, Petar Stojanov, Scott L Carter, Peter Cruz-Gordillo, Michael S Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena,[...]. Cancer Cell 2014
681
29

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.
L Rasche, D Alapat, M Kumar, G Gershner, J McDonald, C P Wardell, R Samant, R Van Hemert, J Epstein, A F Williams,[...]. Leukemia 2019
75
29

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.
S Mithraprabhu, T Khong, M Ramachandran, A Chow, D Klarica, L Mai, S Walsh, D Broemeling, A Marziali, M Wiggin,[...]. Leukemia 2017
70
29

High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma.
J R Mills, D R Barnidge, A Dispenzieri, D L Murray. Blood Cancer J 2017
52
29

Monitoring multiple myeloma by quantification of recurrent mutations in serum.
Even Holth Rustad, Eivind Coward, Emilie R Skytøen, Kristine Misund, Toril Holien, Therese Standal, Magne Børset, Vidar Beisvag, Ola Myklebost, Leonardo A Meza-Zepeda,[...]. Haematologica 2017
35
37

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C Béné, Annemiek Broijl, Hélène Caillon, Denis Caillot,[...]. Lancet 2019
431
27

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.
Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z Orlowski, Philippe Moreau, Nizar Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach,[...]. N Engl J Med 2019
483
27

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients.
Sridurga Mithraprabhu, Rachel Morley, Tiffany Khong, Anna Kalff, Krystal Bergin, Jay Hocking, Ioanna Savvidou, Kathryn M Bowen, Malarmathy Ramachandran, Kawa Choi,[...]. Leukemia 2019
38
34

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
Bruno Paiva, Maria-Belén Vidriales, Jorge Cerveró, Gema Mateo, Jose J Pérez, Maria A Montalbán, Anna Sureda, Laura Montejano, Norma C Gutiérrez, Alfonso García de Coca,[...]. Blood 2008
344
23

Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.
Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri,[...]. Haematologica 2018
23
47

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma.
Nikhil C Munshi, Herve Avet-Loiseau, Kenneth C Anderson, Paola Neri, Bruno Paiva, Mehmet Samur, Meletios Dimopoulos, Margarita Kulakova, Annette Lam, Mahmoud Hashim,[...]. Blood Adv 2020
84
23

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli,[...]. Blood 2011
334
21

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.
Andy C Rawstron, Walter M Gregory, Ruth M de Tute, Faith E Davies, Sue E Bell, Mark T Drayson, Gordon Cook, Graham H Jackson, Gareth J Morgan, J Anthony Child,[...]. Blood 2015
129
21

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.
N Puig, M E Sarasquete, A Balanzategui, J Martínez, B Paiva, H García, S Fumero, C Jiménez, M Alcoceba, M C Chillón,[...]. Leukemia 2014
125
21

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Bruno Paiva, Maria-Teresa Cedena, Noemi Puig, Paula Arana, Maria-Belen Vidriales, Lourdes Cordon, Juan Flores-Montero, Norma C Gutierrez, María-Luisa Martín-Ramos, Joaquin Martinez-Lopez,[...]. Blood 2016
101
21

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.
Yuji Mishima, Bruno Paiva, Jiantao Shi, Jihye Park, Salomon Manier, Satoshi Takagi, Mira Massoud, Adriana Perilla-Glen, Yosra Aljawai, Daisy Huynh,[...]. Cell Rep 2017
73
21

Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
Jens G Lohr, Sora Kim, Joshua Gould, Birgit Knoechel, Yotam Drier, Matthew J Cotton, Daniel Gray, Nicole Birrer, Bang Wong, Gavin Ha,[...]. Sci Transl Med 2016
96
21

Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients.
David Vrabel, Lenka Sedlarikova, Lenka Besse, Lucie Rihova, Renata Bezdekova, Martina Almasi, Veronika Kubaczkova, Lucie Brožová, Jiri Jarkovsky, Hana Plonkova,[...]. Eur J Haematol 2020
13
76

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, Henk M Lokhorst, Hartmut Goldschmidt, Laura Rosinol, Paul Richardson, Simona Caltagirone, Juan José Lahuerta, Thierry Facon,[...]. J Clin Oncol 2015
21

Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.
Marion Eveillard, Even Rustad, Mikhail Roshal, Yanming Zhang, Amanda Ciardiello, Neha Korde, Malin Hultcrantz, Sydney Lu, Urvi Shah, Hani Hassoun,[...]. Br J Haematol 2020
22
45

International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials.
Luciano J Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Gordon Cook, Robert F Cornell, Sarah A Holstein,[...]. Leukemia 2021
40
25

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.
Twyla B Bartel, Jeff Haessler, Tracy L Y Brown, John D Shaughnessy, Frits van Rhee, Elias Anaissie, Terri Alpe, Edgardo Angtuaco, Ronald Walker, Joshua Epstein,[...]. Blood 2009
342
19

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
Leo Rasche, Edgardo Angtuaco, James E McDonald, Amy Buros, Caleb Stein, Charlotte Pawlyn, Sharmilan Thanendrarajan, Carolina Schinke, Rohan Samant, Shmuel Yaccoby,[...]. Blood 2017
122
19

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
Manuela Gambella, Paola Omedé, Stefano Spada, Vittorio Emanuele Muccio, Milena Gilestro, Elona Saraci, Sara Grammatico, Alessandra Larocca, Concetta Conticello, Annalisa Bernardini,[...]. Cancer 2019
27
33

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.
M Ladetto, M Brüggemann, L Monitillo, S Ferrero, F Pepin, D Drandi, D Barbero, A Palumbo, R Passera, M Boccadoro,[...]. Leukemia 2014
211
19

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods.
Mikhail Roshal, Juan A Flores-Montero, Qi Gao, Maesa Koeber, Jessica Wardrope, Brian G M Durie, Ahmet Dogan, Alberto Orfao, Ola Landgren. Blood Adv 2017
60
19

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Kenneth C Anderson, Daniel Auclair, Gary J Kelloff, Caroline C Sigman, Hervé Avet-Loiseau, Ann T Farrell, Nicole J Gormley, Shaji K Kumar, Ola Landgren, Nikhil C Munshi,[...]. Clin Cancer Res 2017
58
19

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
L Sanoja-Flores, J Flores-Montero, J J Garcés, B Paiva, N Puig, A García-Mateo, O García-Sánchez, A Corral-Mateos, L Burgos, E Blanco,[...]. Blood Cancer J 2018
51
19

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson,[...]. Lancet Oncol 2014
19


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.